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Objectives: To test questions usable in an ambulatory clinic to identify persons
likely to have chronic obstructive pulmonary disease (COPD).
Methods: Analyses were performed as part of a study to identify patients with likely
COPD in the Glenfield UK primary care clinic. Patients age 40 and older were recruited
based on one of the following criteria: (1) respiratory medications in previous 2 years;
(2) history of smoking or (3) history of asthma with no current medications based on
case notes. Consenting patients reported smoking history, symptoms, and personal and
family history of respiratory conditions. Spirometry with reversibility was conducted to
ATS standards. Analyses were performed on this database to test questions for
identifying patients with COPD from a sample of patients with a positive smoking
history. Multivariate logistic regression identified the question set that best
discriminated COPD from other conditions using receiver operating characteristic
curves. The usefulness of a simple scoring system was assessed.
Results: The study sample included 369 current and former smokers. Patients were
diagnosed as: COPD ¼ 62 (16.8%); asthma ¼ 30 (8.1%); or no obstructive lung
disease ¼ 277 (75.1%). The best questions for discriminating between persons with
and without COPD included items on age, dyspnoea on exertion, and wheeze. This
set of questions identified COPD patients with a sensitivity of 77.4–87.1% and
specificity of 71.3–76.2%.
Conclusions: A simple questionnaire can facilitate the diagnosis of COPD in a
primary care setting.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Background
Underdiagnosis of chronic obstructive pulmonary
disease (COPD) and resulting lack of treatment
remains a problem worldwide.1–4 Lack of physician
awareness of COPD as an important disease may
lead to failure to consider COPD as a diagnosis.
Primary care physicians may not use spirometry to
detect COPD, as recommended in published guide-
lines, for a variety of reasons including limited
access, lack of provider training, patient presenta-
tion only when overt respiratory infections man-
ifest, and time constraints in a busy practice
setting.3–5
Thus, primary care physicians are faced with the
challenge of identifying patients with COPD among
a general practice population. Recently published
guidelines by the UK National Institute for Clinical
Excellence (NICE) have recommended that those
patients with a risk factor and symptoms of
exertional breathlessness, chronic cough, regular
sputum production, frequent winter ‘bronchitis’ or
wheeze be considered as possibly having COPD.6
However, this recommendation is graded
’ ’
D’’
because of limited evidence quantifying the rela-
tionship between specific patient-reported infor-
mation and diagnosis. International guidelines
similarly suggest that symptoms of chronic cough
and sputum production may be helpful in diagnosis,
progressive dyspnoea is included for later disease
stages, and wheeze is not mentioned as a symptom
valuable in the diagnosis of COPD.7
Recent development efforts have focused on tools
that aim to help identify COPD patients.8,9 This study
adds to these efforts by examining the discriminatory
value of individual questions in a primary care
clinical setting. Our hypothesis was that some
selected set of questions could be used to identify
persons at increased likelihood of COPD with
accuracy sufficient to serve as a case-finding tool.Objectives
This study aimed to identify a set of questions that
might be used to identify COPD among an ambula-
tory patient population of persons at increased risk.
We aimed to accomplish this through analyses of a
rich clinical database, which includes self-reported
patient data as well as the results of spirometry and
reversibility testing. We tested the predictive
ability of questions to distinguish COPD patients
from those who do not have COPD from a sample of
patients with a positive smoking history.Methods
Glenfield Ambulatory COPD Database
Analyses for this study were performed using a
database of patients recruited from the Glenfield
UK primary care clinic. Data were collected from
patients in the Glenfield UK primary care practice
from October 1997 to April 2002. This practice is in
a semi-urban area on the northern edge of
Leicester (UK) and serves approximately 12,000
patients. This data collection effort was also to
obtain detailed information on symptoms and
quality-of-life issues experienced by patients with
respiratory conditions and to form the baseline for
an intervention study in a primary care COPD
population. The study protocol was approved by
the Leicestershire local research ethics committee.
Patients age 40 and older were selected for the
creation of this study database based on at least
one of the following: (1) received respiratory
medications (bronchodilators, leukotriene inhibi-
tors, cromoglycates, or inhaled corticosteroids) in
the previous 2 years; (2) history of smoking; or (3)
history of asthma with no current medications
based on a review of medical records. Eligible
patients received an invitation letter describing the
creation of the study database and requesting that
they schedule a visit for data collection. Patients
taking salbutamol or terbutaline were asked to
withhold medications on the day of the scheduled
visit; patients on any long-acting beta agonists
were asked to withhold medications for 2 days prior
to the scheduled visit. After obtaining patient
consent, a trained respiratory nurse interviewed
participating patients to obtain information on
smoking history, personal and family history of
respiratory and atopic conditions, and the presence
and frequency of key respiratory symptoms.
Spirometry was performed on the study partici-
pants under standardised conditions using a Micro-
Med handheld spirometer and recorded using Spida
software. Testing for each individual was conducted
a minimum of three times or until results repro-
ducible to within 5% were obtained. The highest
reproducible FEV1 and FVC were recorded. All
patients recruited on a basis of respiratory medica-
tions or history of asthma also received reversibility
testing using a nebuliser (5mg salbutamol). For
those recruited on a basis of smoking history alone,
reversibility testing was conducted only for those
with a pre-bronchodilator FEV1o80% of predicted.
A physician supervised the spirometry and data
collection, and also reviewed all spirometry results
to verify that the procedure complied with the
recommendations of the American Thoracic Society
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spirometry.10 An overall clinical impression was
entered by a physician. This clinical impression was
used in defining the study diagnoses, as discussed
below.
These data were not primarily collected with the
intent of developing a diagnostic questionnaire, but
as a part of the baseline for an intervention study in
a primary care setting. A secondary objective was
to test questions that could be useful in COPD
diagnosis and analysis was performed using this
dataset to test the discriminatory capability of
several variables to facilitate diagnosis.Study diagnosis definitions
In order to retrospectively test the discriminatory
ability of questions in the dataset, study diagnoses
were assigned. Whereas clinical diagnoses fre-
quently include physician assessments repeated
over time, the study diagnoses had to be deter-
mined based upon objective data collected at one
point in time. Diagnostic definitions were based
upon the guidelines developed by the Global
Initiative for Chronic Obstructive Lung Disease
(GOLD) and Global Initiative for Asthma (GINA)
operationalised for adaptation to this study setting.
The study definition of COPD was based on the
spirometric criteria as outlined in the GOLD
definition.7 The study definition of asthma, in
keeping with GINA recommendations, was based
on a clinical impression corroborated with spiro-
metric findings.11 The absence of obstructive
disease was also based on spirometric and clinical
criteria: a lack of obstruction and no indications of
lung disease. Thus, the diagnoses were:
COPD: FEV1=FVCo70% and lack of reversibility, as
defined below
Asthma: Reversibility and clinical impression of
asthma
No obstructive disease: FEV1=FVCX70% and no
clinical impression of obstructive lung
disease
Reversibility was defined as an increase in FEV1 of
200ml and 15% from the pre-bronchodilator FEV1.
Because this was a retrospective analysis rather
than a clinical study, we excluded patients for
whom there was an increased probability of
misclassification bias. Thus, we excluded patients
with FEV1=FVCo70% with reversibility or clinical
impression of asthma, as well as patients known to
have other respiratory conditions such as sarcoido-
sis and bronchiectasis.Subject selection
To test the ability of questions to distinguish
patients with COPD from those who did not have
COPD, we selected those patients from the data-
base with a positive smoking history and who met
the study diagnostic criteria for COPD, asthma, or
no obstructive disease. This sample approximates
the situation of identifying COPD in the high-risk
population of ever smokers. The analysis identified
questions to distinguish between those with COPD
from all others in the sample.Analytic plan
Both bivariate and multivariate statistical methods
were used. Correlations of individual variables with
the study diagnoses were evaluated bivariately,
with Pearson’s w2 reported. Multivariate logistic
regression analysis sought to identify the set of
questions that best discriminated COPD from other
conditions using receiver operating characteristic
(ROC) curves.
To examine the relative value of multiple
response items versus single response items, two
sets of regression results are presented. The first
set uses all response categories for smoking history
and symptoms questions (e.g. Cough: None/Occa-
sional/Only with exacerbations/Most mornings/
Every day). The second set of results collapses
multiple responses into a single response category
for each variable (e.g. Cough occasionally or more
often).
Using relative weights for each variable derived
form the odds ratios in the multivariate logistic
regressions, a simple scoring system was devel-
oped. This scoring system was then used to
evaluate the overall performance of a potential
questionnaire. Questionnare performance was
evaluated in different diagnostic groups. In addi-
tion to the total area under the ROC curve,
performance was tested using sensitivity, specifi-
city, and the predictive values of positive and
negative tests.
All analyses were conducted with STATA 7.0.12Results
A total of 1195 patients were initially identified for
the original database creation, with 624 (52.2%)
eligible patients consenting to participate and
completing data collection. This represented the
sample frame from which the subjects for this
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selected.
The characteristics of the study sample are
summarised in Table 1. A total of 369 patients with
positive smoking history were included. Their mean
age was 61.7 years, and 52% of the patients were
male. More than 60% had more than 20 pack-years
smoking exposure. Sixty-two (16.8%) had a study
diagnosis of COPD.
Several data elements were available in the
dataset that could be used to identify COPD
patients. To demonstrate the potential discrimina-
tory ability of these
’ ’
candidate variables,’’ the
bivariate relationships between these variables and
the study diagnosis were examined (Table 2). For
persons with and without a study diagnosis of
COPD, the proportion of subjects with individual
variable characteristics are presented. For exam-
ple, 4.8% of persons with a study diagnosis of COPD
were aged 40–54 years, compared with 37.1%
of persons without a study diagnosis of COPD.
All variables except pack-years of smoking history
demonstrated statistically significant bivariate
relationships with a study diagnosis of COPD.
Persons with COPD were more likely to be older,
to be former smokers, to report higher levels of
symptoms.
To determine the true predictive ability of each
variable in a multi-item questionnaire, the strength
of the relationship between COPD and each vari-
able was tested while controlling for other pre-
dictors. Table 3 presents these results, showing
performance of the variables in a multivariate
framework. The table lists odds ratios (ORs), which
are interpreted as the odds of having COPD. In thisTable 1 Study sample characteristics.
Total n 369
Age in years (mean) 61.7
Age categories
40–54 years 117 (31.7%)
55–69 years 151 (40.9%)
70+years 101 (27.4%)
Male sex 192 (52.0%)
Smoking status
Former smoker 169 (45.9%)
Current smoker 199 (54.1%)
Pack-year categories
0–19 pack-years 135 (36.6%)
20+pack-years 234 (63.4%)
Study diagnosis
COPD 62 (16.8%)
Asthma 30 (8.1%)
No obstructive lung disease 277 (75.1%)context, ORs greater than 1.0 are predictive of
COPD. Results for the full set of response items
(Model 1) and those for the collapsed-category
items (Model 2) are shown side by side. For Model 1,
age, dyspnoea on stair-climbing or light exercise,
and wheezing every day were significantly asso-
ciated with COPD. In Model 2, age, coughing
occasionally or more often, and dyspnoea with
any level of exercise were significant predictors of
COPD.
Table 4 lists ROC parameters demonstrating the
performance of the best combination of questions
to identify patients with COPD. For this analysis,
the
’ ’
best’’ combination was defined as that with
the maximum area under the ROC curve (AUC).
Performance characteristics of these question sets
were determined using scoring ranges that max-
imised overall performance. The best question set
performed well, with sensitivities ranging from
77.4% using multiple response categories (Model 1)
to 87.1% using collapsed categories (Model 2).
Specificities ranged from 71.3% (Model 2: collapsed
responses) to 76.2% (Model 1: multiple responses).
The total AUC was slightly higher for Model 1,
suggesting that symptom questions that allowed
multiple responses (Wheeze: None, Occasional, At
least once per week, Every day) had a slightly
greater overall predictive ability than those where
these multiple responses are
’ ’
collapsed’’ into a
binary
’ ’
Yes/No’’ response.
Fig. 1 depicts the distribution of scores among
the different diagnostic groups. In these box plots,
the central box indicates the median and 25th and
75th percentiles. The 10th and 90th percentiles are
displayed as extensions to the box, and outliers are
shown as individual points beyond the 10th and
90th percentiles. COPD patients had higher scores
on average than did non-COPD patients (Po0:001),
and this difference was most pronounced among
persons with moderate and severe COPD. There
were also statistically significant differences be-
tween COPD patients and asthma patients
(Po0:001), although there was considerable
overlap between these two groups. There was a
slight trend in increasing scores with increasing
severity among COPD patients, which did not reach
significance (P40:200).Discussion
This study shows that simple, symptom-based
questions can aid the identification of COPD
patients in primary care. A recent literature review
identified only four published studies examining the
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Table 2 Frequency distribution of variables by diagnosis (n ¼ 369).
Study diagnosis
Variable Categories COPD (%) No COPD (%) P-value
Age (years)
40–54 4.8 37.1
55–69 29.0 43.3 o0.001
70+ 66.2 19.6
Smoking status
Former smoker 62.9 42.5 0.003
Current smoker 37.1 57.5
Pack-years
0–19 37.1 36.5 0.927
20+ 62.9 63.5
Cough
None 22.6 50.8
Occasional 12.9 13.4
Only with exacerbations 14.5 8.9 o0.001
Most mornings 19.4 10.2
Every day 30.6 16.7
Dyspnoea
None 9.7 43.8
Only on vigorous exercise 17.7 23.7
On climbing stairs 27.4 17.1 o0.001
On light exercise 38.7 8.9
At rest 6.5 6.6
Wheeze
None 26.2 53.1
Occasional 39.3 36.7 o0.001
At least once/week 9.8 4.6
Every day 24.6 5.6
COPD diagnostic questions 1315use of questions in identifying COPD.13 Only one of
these was performed in a primary care setting, but
that study focused primarily on the effectiveness of
case-finding efforts.7 The current study contributes
a comparative assessment of which symptom
questions may perform best in identifying COPD.
In addition, it quantifies the likely performance of
symptom-based questionnaires, and points to how
future questionnaires might be implemented in
practice.Predictive ability of questions
These results indicate that, for COPD screening
among patients who have a smoking history, the
following questions are strong predictors of COPD: Increasing age;
 Coughing occasionally or more often;
 Presence of dyspnoea on exertion; and
 Daily wheezing.This adds support to the statements in guidelines
that suggest that symptoms may be helpful in
identifying those who require investigation for
COPD among patients at risk.6,7 It also supports
the use of the symptom of wheeze suggested in
some guidelines but not others. van Schayck and
colleagues found that cough was correlated with
airway obstruction, but wheeze and dyspnoea were
not.8 That study used a different definition of
airway obstruction (FEV1o80% of predicted) how-
ever, and excluded smokers taking medications for
pulmonary conditions, making comparisons with
our results difficult.
Several other questions exhibited significant
bivariate relationships but did not have substantial
predictive ability in a multivariate framework. For
example, smoking status and pack-years were
notably not significant discriminators. This is likely
due to the overall heavy smoking burden across the
entire population (ever smokers) in whom this
analysis was performed. Cough was disappointing
as a discriminator in the multivariate analysis,
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Table 3 Predictive ability of variables in multivariate models.
Item Categories Odds ratio 95% CI Categories Odds ratio 95% CI
Model 1: Multiple response categories Model 2: Collapsed response categories
Age (years)
40–54 1.0 (reference) 40–54 1.0 (reference)
55–69 4.5 1.2–17 55–69 4.6 1.3–16
70+ 16 4.4–61 70+ 21 6.1–73
Smoking status
Former smoker 1.0 (reference)
Current smoker 0.6 0.28–1.3
Pack-years
0–19 1.0 (reference) 0–19 1.0 (reference)
20+ 1.3 0.62–2.9 20+ 0.93 0.47–1.8
Cough
None 1.0 (reference) None 1.0 (reference)
Occasional 0.94 0.31–2.9 Occasional or more often 2.4 1.2–4.7
Only with exacerbations 3.1 0.98–9.9
Most mornings 2.2 0.75–6.2
Every day 1.8 0.65–5.0
Dyspnoea
None 1.0 (reference) None 1.0 (reference)
Only on vigorous exercise 3.1 0.95–10.4 On any exercise or at rest 3.0 1.5–5.9
On climbing stairs 4.8 1.5–15.2
On light exercise 8.3 2.6–26
At rest 2.4 0.50–12
Wheeze
None 1.0 (reference)
Occasional 1.2 0.54–2.7
At least once/week 1.3 0.35–4.8 None or less than every day 1.0 (reference)
Every day 3.1 1.1–9.5 Everyday wheeze 2.2 0.89–5.5
Log likelihood ¼ 113.86, Log likelihood ¼ 121.10.
Odds of having COPD.
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Figure 1 Performance of question scoring by diagnostic
groups.
Table 4 Overall performance of questionnaire.
Sensitivity Specificity Positive
predictive value
Negative
predictive value
Area under (ROC)
curve
Model 1: Multiple
responses
77.4 76.2 39.7 94.4 85.9
Model 2:
Collapsed
responses
87.1 71.3 38.0 96.5 85.0
COPD diagnostic questions 1317although it was suggestive in bivariate analysis.
This may be due to a relatively high prevalence of
cough among the entire dataset (i.e. those with
and without a study diagnosis) and to possible
strong correlations between cough and other
symptom measures.14
For dyspnoea and wheeze, questions that al-
lowed patients multiple responses (Wheeze: None,
Occasional, At least once per week, Every day) had
a slightly greater overall predictive ability than did
those where these multiple responses are
’ ’
col-
lapsed’’ into a binary
’ ’
Yes/No’’ response; the area
under the ROC curve (AUC) increased slightly in
these cases. However, comparisons of results for
multiple response categories should be treated
with caution. There are only slight improvements in
predictive ability when multiple responses to
symptom questions are analysed. In a real-life
clinic setting, the simplicity of single responses
(i.e.
’ ’
yes/no’’) may outweigh any small advantage
in discriminatory power. However, it may not be
known a priori which response category provides
the greatest predictive power. For example, in the
current study, having a wheeze every day was
predictive of COPD, while wheezing less frequentlythan every day was not. This does not suggest that
individual patients with occasional or intermittent
wheezing cannot have COPD, but implies that, in
this patient population, the presence of daily
wheezing was significantly more discriminatory
than less frequent wheezing. Validation in addi-
tional practice settings may be required to identify
the most appropriate response categories.
Finally, the average age in our sample was 61.7
years. Since the mean age at detection of COPD in
the UK is closer to 55 years,6 the most effective
questions for identifying COPD may be somewhat
different in a younger patient population.Scoring
The ROC parameters and score performance shown
in Fig. 1 suggest that a short group of questions
could easily differentiate between COPD and non-
COPD patients. The performance of these questions
is enhanced with increasing severity of COPD and is
greatest in moderate to severe patients. It is likely
that discriminatory ability also varies with asthma
severity; unfortunately, there was insufficient
information in the clinical database to stratify the
asthma diagnosis in this way.
These results have important implications for
clinical practice. This type of information can be
used to identify persons for whom spirometry is
most appropriate, increasing the efficiency of case-
finding efforts. Second, by focusing on current and
former smokers aged 40 and older, case-finding
efforts may be directed toward a population
subgroup with higher prevalence of obstruction.Limitations
By using the GOLD Stage I criteria—a relatively
loose definition—to define COPD, there is little
doubt that some patients with clinically insignif-
icant COPD may have been included in our sample.
In particular, the usefulness of the GOLD criteria
may be diminished in older patients.15 Despite our
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possible that some genuine asthma patients could
have been misclassified as having COPD. Since our
goal was not to establish a definitive diagnosis,
however, a small amount of misclassification would
probably have had a limited effect on our findings.
These issues highlight the need for a prospective
study.
Conclusions and recommendations
The predictive power of questions, as demon-
strated through retrospective analyses, suggests
that a questionnaire could be very useful to
facilitate the identification of patients with COPD
in a primary care setting. We tested one possible
scenario for the use of such a questionnaire.
Screening patients with a smoking history, for
example, can be useful in case-finding whereby
patients are identified for further examination and
diagnostic confirmation with spirometry. The in-
formation required for the use of such question-
naires could easily be obtained by patient self-
report in the primary care setting. Given the
current level of misdiagnosis and under-diagnosis
of COPD worldwide, such questionnaires could
prove of significant value to patients, physicians,
and payers.
Although the use of questionnaires is not in-
tended to replace the need for spirometry, we
believe that they can be very useful to facilitate
the diagnosis. For example, in clinical settings
where spirometry is not available, GOLD clearly
recommends the use of
’ ’
other available tools.’’7
Similarly, in settings where spirometry is not readily
available, the use of such a questionnaire could
serve a triage function to appropriately allocate
scarce resources. GOLD also highlights the value of
symptoms and risk factor exposure in aiding
diagnosis and differential diagnosis;7 a view sub-
stantiated by our findings. Finally, in settings where
spirometry is generally available but underutilised,
these questionnaires could remind physicians of the
need for further diagnostic evaluation and con-
sideration of spirometric testing as suggested
by NICE.
This analysis is valuable in identifying general
question types that are most predictive of COPD.
Identification of specific questions—and question
sets—that have the highest predictive ability in agiven population will require further prospective
development and validation.References
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